Abstract:Acute inflammatory exacerbations (AIEs) represent immune-driven deteriorations of many chronic lung conditions, including COPD, asthma, and pulmonary fibrosis (PF). The first line of therapy is represented by broad-spectrum immunomodulation. Among the several inflammatory populations mobilizing during AIEs, eosinophils have been identified as promising indicators of an active inflammatory exacerbation. To better study the eosinophil-parenchymal crosstalk during AIE-PF, this work leverages a clinically relevant model of inflammatory exacerbations triggered by inducible expression of a mutation in the alveolar epithelial type 2 cell Surfactant Protein-C gene [SP-C I73T ]. Unbiased single-cell sequencing analysis of controls and SP-C I73T mutants at a time coordinated with peak eosinophilia (14 days) defined heightened inflammatory activation, chemotaxis, and survival signaling (IL-6, IL-4/13, STAT3, Glucocorticoid Receptor, mTOR, and MYC) in eosinophils. To study the impact of eosinophils in inflammatory exacerbations, the SP-C I73T line was crossed with eosinophil lineage deficient mice (GATA1 Δdbl ) to produce the SP-C I73T GATA1 KO line. Time course analysis (7–42 days) demonstrated improved lung histology, survival, and reduced inflammation in SP-C I73T GATA1 KO cohorts. Spectral flow cytometry of tissue digests confirmed eosinophil depletion in GATA1 KO mice and the absence of a compensatory shift in neutrophils and immature monocyte recruitment. Eosinophil deletion resulted in progressive monocyte-derived macrophage accumulation (14 days post-injury), combined with declines in CD3 + CD4 + lymphocyte and B220 + B cell abundance. Histochemical analysis revealed atypical inflammatory cell activation in SP-C I73T GATA1 KO mice, with reduced numbers of Arg-1 + and iNOS + cells, but increases in tgfb1 mRNA expression in bronchoalveolar lavage cells and tissue. Dexamethasone treatment (1 mg/kg daily, i.p.) was utilized to investigate corticosteroid efficacy in highly eosinophilic exacerbations induced by mutant SP-C I73T . Dexamethasone successfully reduced total and eosinophil (CD11b + SigF + CD11c − ) counts at 14 days and was linked to reduced evidence of structural damage and perivascular infiltrate. Together, these results illustrate the deleterious role of eosinophils in inflammatory events preceding lung fibrosis and demonstrate the efficacy of corticosteroid treatment in highly eosinophilic exacerbations induced by mutant SP-C I73T .

SPLUNC1 as a biomarker of pulmonary exacerbations in children with cystic fibrosis

Sputum Proteomics reveals unique signatures linked to key outcomes in cystic fibrosis trials.

Pulmonary exacerbations in early cystic fibrosis lung disease are marked by strong modulation of CD3 and PD-1 on luminal T cells

Airway inflammation accelerates pulmonary exacerbations in cystic fibrosis

A Pulmonary Exacerbation Risk Score among Cystic Fibrosis Patients Not Receiving Recommended Care.

The SPLUNC1-βENaC complex prevents Burkholderia cenocepacia invasion in normal airway epithelia

Relevance between clinical status and exhaled molecules related to neutrophilic inflammation in pediatric cystic fibrosis

Pilot study of inflammatory biomarkers in matched induced sputum and bronchoalveolar lavage of 2-year-olds with cystic fibrosis

Key inflammatory markers in bronchoalveolar lavage predict bronchiectasis progression in young children with CF

Predicting return of lung function after a pulmonary exacerbation using the cystic fibrosis respiratory symptom diary-chronic respiratory infection symptom scale

LSC Abstract – Early biomarkers indicating the development of neonatal chronic lung disease defined by clinical and imaging parameters

The cumulative effect of inflammation and infection on structural lung disease in early cystic fibrosis

Inflammation in children with cystic fibrosis: contribution of bacterial production of long-chain fatty acids

Changes in urinary glutathione sulfonamide (GSA) levels between admission and discharge of patients with cystic fibrosis

SLPI deficiency alters airway protease activity and induces cell recruitment in a model of muco-obstructive lung disease

Relationship of Pneumocystis antibody responses to paediatric asthma severity

Utilizing centralized biorepository samples for biomarkers of cystic fibrosis lung disease severity

Cytokines Measured in Nasal Lavage Compared to Induced Sputum in Patients with Mild Cystic Fibrosis

Immunophenotyping of Acute Inflammatory Exacerbations of Lung Injury Driven by Mutant Surfactant Protein-C: A Role for Inflammatory Eosinophils

Lung-Kidney Axis in Cystic Fibrosis: Early Urinary Markers of Kidney Injury Correlate with Neutrophil Activation and Worse Lung Function

Reduced levels of liver kinase B1 in small extracellular vesicles as a predictor for chronic lung allograft dysfunction in cystic fibrosis lung transplant recipients